Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2. These are administrative changes unrelated to the clinical trial details.
    Difference
    0.1%
    Check dated 2025-12-23T21:36:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:00:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The funding/operational status notice was removed from the page; trial details and study information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:11:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No significant content changes were detected; the page still presents the study overview, eligibility criteria, design, and outcome measures.
    Difference
    0.5%
    Check dated 2025-11-03T21:04:17.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    4%
    Check dated 2025-10-06T05:37:58.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Update to v3.1.0 with removal of the Ovarian cancer resource from GARD and removal of v3.0.2; overall, a small scope/content shift and new release note rather than substantive page content changes.
    Difference
    0.5%
    Check dated 2025-09-29T03:09:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.